Oncology
Oncology
Advertisement
Jordana JampelBreast Cancer | November 19, 2024
Twelve chemicals were associated with increased breast cancer risk.
Read More
Jordana JampelMelanoma | November 18, 2024
Seventy-two percent of tumor specimens contained histologically defined LAs.
Jordana JampelBreast Cancer | November 18, 2024
Heterozygosity in BRCA1 genes is not enough to prevent tumor proliferation, according to researchers out of Harvard.
Jordana JampelGynecologic Cancer | November 13, 2024
Deep learning algorithms combined with MRI could have a major impact on diagnosing patients with high-risk disease.
Rob DillardBreast Cancer | November 12, 2024
Thyroid and parathyroid dysfunction is common among women with breast cancer following radiotherapy.
Jordana JampelHead and Neck Cancer | November 11, 2024
Researchers aimed to find a marker to accurately predict the prognosis of HNSCC and to find novel immune targets.
Jordana JampelMelanoma | November 11, 2024
The analysis included the CheckMate trials that involved ICI treatment-naive unresected/metastatic melanoma.
Jordana JampelBreast Cancer | November 11, 2024
A study aimed to assess TILs as predictors of response to neoadjuvant chemotherapy in locally advanced breast cancer.
Dr. John Fruehauf, EvolentMelanoma | November 7, 2024
Dr. John Fruehauf, Evolent, talks about a new standard of care in the treatment of stage III melanoma. 
Jordana JampelGynecologic Cancer | November 6, 2024
A Mendelian randomized analysis was performed to determine the effects of anti-CD20 antibodies on endometrial cancer.
Jordana JampelBreast Cancer | November 8, 2024
Researchers designed a interpretable deep learning model for detecting BRCA pathogenic variants of breast cancer.
Jordana JampelHead and Neck Cancer | November 7, 2024
The combo's use for conjunctival melanoma demonstrates the combinations high efficacy in treating complex disease.
Rob DillardBreast Cancer | October 31, 2024
A novel method can assess which patients with TNBC could benefit from immunotherapy.
Jordana JampelBreast Cancer | October 28, 2024
This could be a needed breakthrough for those predisposed to breast and ovarian cancer mutations.
Jordana JampelGynecologic Cancer | October 25, 2024
There is a compelling case for the PK benefit of GLP-1s on certain cancer cell lines.
Laura LitwinHead and Neck Cancer | October 23, 2024
The single-center, prospective study evaluated patient questionnaires to assess quality of life and physical function.
Rob DillardGynecologic Cancer | October 23, 2024
Krystina Dunston spoke about the findings of a study which showed potential in slowing tumor growth in endometrial cancer.
Rob DillardHead and Neck Cancer | October 23, 2024
BANF1 is a prognostic biomarker that can promote tumor expression in patients with HNSCC.
Jordana JampelBreast Cancer | October 25, 2024
BUB1 has potential prognostic value in therapy decision-making across breast cancer characterizations.
Rob DillardBreast Cancer | October 23, 2024
New research shows that selenium, a mineral commonly found in Brazil nuts, could hold the key to stopping the spread of TNBC.
Advertisement
Advertisement
Advertisement
Latest News

November 20, 2024